Back

Optimal Stereotactic Body Radiotherapy Dosage For Hepatocellular Carcinoma

2020-02-27 oncology Title + abstract only
View on medRxiv
Show abstract

Background and purposeThe optimal dose and fractionation scheme of stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma (HCC) remains unclear due to different tolerated liver volumes and degrees of cirrhosis. We compared the effectiveness of stereotactic body radiation therapy dosing regimens for hepatocellular carcinoma (HCC). Methods and materialsThis single-center retrospective study included 604 patients treated during 2011-2017. Biologically effective dose (BED10) and eq...

Predicted journal destinations